Pfizer's vaccine for Clostridium difficile (C. diff) looks like it may join a growing list of candidates that have been shelved or delayed, after the shot failed to meet its primary objective in a ...

RBX2660 was well-tolerated and achieved its primary endpoint of preventing C. diff. recurrence; patients treated with RBX2660 exhibited a treatment success rate of 78.8% compared with a historical ...

C. diff is a problem around the country. Other local hospitals that scored worse than the national benchmark on C. diff were Carondelet St. Mary’s Hospital and Tucson Medical Center.

Senate Vote 327 June 26, 2025 5:41PM ET On the Nomination PN13-7 Kenneth Kies, of Virginia, to be an Assistant Secretary of the Treasury ...